Healthcare
Norwest backs India hospital, HealthQuad marks 3x exit
Norwest Venture Partners has invested INR 4.5bn (USD 54m) in Indian hospital operator Regency Healthcare, facilitating an exit for HealthQuad, which generated a 3x return.
Five V backs Australia radioactive drug maker
Australia’s Five V Capital has confirmed an investment of undisclosed size in Cyclotek, a radioactive drug maker positioning itself as part of an industry transition toward personalized medicine.
MassMutual Ventures leads Series A for India's Sugarfit
Sugarfit, an India-based health technology start-up that helps people manage type-two diabetes with a view to reversing the condition, has raised USD 11m in Series A funding.
Polaris leads $27m round for Singapore's Engine Biosciences
US healthcare and life sciences growth investor Polaris Partners has led a USD 27m Series A round for Singapore-based cancer medicine developer Engine Biosciences.
CVC buys majority stake in Philippines hospital business
CVC Capital Partners has acquired a 63.94% stake in Philippines-based hospital operator The Medical City (TMC) following the completion of a tender offer.
OrbiMed raises $4.3b for global, Asia funds
Healthcare investor OrbiMed has raised USD 4.3bn for its latest set of global funds, including its fifth Asia-focused vehicle.
CBC hits second close on China life science real assets fund
Specialist healthcare investor CBC Group has reached a second close on its China-focused life science real assets fund with USD 875m in commitments.
East targets $30m for Indonesia healthcare VC fund
East Ventures has launched a dedicated Indonesia healthcare innovation fund with a target of USD 30m.
Quadria hits $500m first close on third healthcare fund
Singapore-based healthcare specialist Quadria Capital has reached a first close of USD 500m on its third flagship fund. The target is USD 800m.
Quest backs Vietnam robotic prosthetics start-up
Singapore’s Quest Ventures has confirmed an investment of undisclosed size in Vietnam-based robotic prosthetics start-up Vulcan Augmetics.
China's Atom Bioscience raises $83m
Chinese inflammatory and metabolic disease drug developer Atom Bioscience has raised USD 83m in Series D funding led by local biotech specialist Kaitai Capital.
BPEA EQT acquires Australia's VetPartners
BPEA EQT has agreed to acquire VetPartners, operator of Australia and New Zealand’s largest network of pet clinics and hospitals, from National Veterinary Associates (NVA).
Mubadala supports buyout of Korea's Osstem Implant
Mubadala Investment has invested in Osstem Implant, a Korean manufacturer of dental implants that was taken private by MBK Partners and UCK Partners (formerly Unison Capital Korea) earlier this year.
Japan's WiL joins $27m round for health platform Micin
Japan-US cross-border investor World Innovation Lab (WiL) has joined a JPY 4bn (USD 27.3m) Series C round for Tokyo-based telemedicine and health platform Micin.
LeapFrog eyes February close, claims significant progress on fundraise
Impact investor LeapFrog Investments expects to close its fourth flagship fund in February, with a source close to the situation adding that "a significant share" of the targeted USD 1bn has already been raised.
True North agrees $326m India health insurance exit
True North has agreed to sell about 20% of its stake in Indian insurance company Niva Bupa to its UK-based joint venture partner, Bupa, for approximately INR 27bn (USD 326m).
L Catterton backs beauty industry biotech supplier
L Catterton has led a CNY 200m (USD 27m) Series B round for Trautec, a China-based biotech start-up that develops synthetic proteins used in beauty and healthcare products.
China healthcare AI start-up Huimei gets $41m Series D
Eastern Bell Capital has led a Series D round of more than CNY 300m (USD 41m) for Huimei Cloud Technology, a China-based provider of artificial intelligence-enabled (AI) software that helps doctors make clinical decisions.
Deal focus: Riding the wave in India single-speciality hospitals
TPG Capital’s Asia Healthcare Holdings has tapped a rich vein for private equity in acquiring India’s only nephrology and urology hospital. Technological leadership will support expansion
Matrix, HongShan back China's Qihan Biotech
Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.
Indian regulator approves Blackstone's purchase of Care Hospitals
The Blackstone Group’s proposed acquisition of India-based hospital chain Care Hospitals from TPG’s The Rise Fund has won approval from the national competition regulator.
China's Lynk Pharmaceutical increases Series C to $44m
China-based drug developer Lynk Pharmaceuticals has closed a second tranche of Series C funding, taking the overall size of the round to CNY 322m (USD 44m).
TPG healthcare platform acquires India hospital chain
Asia Healthcare Holdings (AHH), a platform backed by TPG Capital and GIC, has acquired a majority stake in India’s Asian Institute of Nephrology and Urology (AINU) for about USD 72.2m.
PE-backed Concord Healthcare pursues HK IPO
Concord Healthcare Group, an onshore subsidiary of US-listed Chinese healthcare business Concord Medical, has filed for an IPO in Hong Kong.